2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride

C14H20BrClN2O2 — CID 120575570

IUPAC2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride
SMILESCC1NCCCC1NC(=O)COc1ccc(Br)cc1.Cl
InChIInChI=1S/C14H19BrN2O2.ClH/c1-10-13(3-2-8-16-10)17-14(18)9-19-12-6-4-11(15)5-7-12;/h4-7,10,13,16H,2-3,8-9H2,1H3,(H,17,18);1H
InChIKeyBZOSAXNOIDEPLE-UHFFFAOYSA-N
MW363.68 g/mol
LogP2.51
Rot. Bonds4

About 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride

2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride (PubChem CID 120575570) has the molecular formula C14H20BrClN2O2 and a molecular weight of 363.68 g/mol. Its IUPAC name is 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride.

Molecular Properties

Compound Name2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride
PubChem CID120575570
Molecular FormulaC14H20BrClN2O2
Molecular Weight363.68 g/mol
Exact Mass362.04
IUPAC Name2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride
SMILESCC1NCCCC1NC(=O)COc1ccc(Br)cc1.Cl
InChIInChI=1S/C14H19BrN2O2.ClH/c1-10-13(3-2-8-16-10)17-14(18)9-19-12-6-4-11(15)5-7-12;/h4-7,10,13,16H,2-3,8-9H2,1H3,(H,17,18);1H
InChIKeyBZOSAXNOIDEPLE-UHFFFAOYSA-N
XLogP2.51
TPSA50.36 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500363.68
LogP ≤ 52.51
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Analyze 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(4-methylphenoxy)-N-(2-methylpiperidin-3-yl)acetamide
CID 120576127
2-(4-ethoxyphenyl)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride
CID 120573758
2-(4-bromophenoxy)-N-(2-methylcyclohexyl)acetamide;oxalic acid
CID 171154743
2-(2-chlorophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride
CID 120575020
2-(5-bromo-2-methoxyphenyl)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride
CID 120577760
N-(2-methylpiperidin-3-yl)-2-(2-phenylphenoxy)acetamide;hydrochloride
CID 120577924
N-(2-methylpiperidin-3-yl)-2-(2,4,5-trichlorophenoxy)acetamide;hydrochloride
CID 120577990
2-(4-bromophenoxy)-N-[2-(hydroxymethyl)cyclohexyl]acetamide
CID 103798457
2-(2,5-dichlorophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride
CID 120577794
N-(2-methylpiperidin-3-yl)-3-(4-propan-2-ylphenoxy)propanamide;hydrochloride
CID 120576470
2-(2,4-dichlorophenoxy)-N-(2-methylpiperidin-3-yl)acetamide
CID 120577365
2-(4-bromophenyl)-2-methyl-N-(2-methylpiperidin-3-yl)propanamide;hydrochloride
CID 120575309

Frequently Asked Questions

What is the IUPAC name of 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride?
The IUPAC name of 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride (CID 120575570) is 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride.
What is the SMILES notation for 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride?
The canonical SMILES for 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride is CC1NCCCC1NC(=O)COc1ccc(Br)cc1.Cl.
What is the InChIKey of 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride?
The InChIKey is BZOSAXNOIDEPLE-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H19BrN2O2.ClH/c1-10-13(3-2-8-16-10)17-14(18)9-19-12-6-4-11(15)5-7-12;/h4-7,10,13,16H,2-3,8-9H2,1H3,(H,17,18);1H.
What are the key properties of 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride?
2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride has a molecular weight of 363.68 g/mol, XLogP of 2.51, 4 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-bromophenoxy)-N-(2-methylpiperidin-3-yl)acetamide;hydrochloride is sourced from PubChem (CID 120575570), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).